July 6, 2026: 𝗧𝗼 𝘁𝗵𝗲 𝗖𝗘𝗢𝘀, 𝗖𝗙𝗢𝘀, 𝗣𝗿𝗲𝘀𝗶𝗱𝗲𝗻𝘁𝘀, 𝗖𝗠𝗢𝘀, 𝗮𝗻𝗱 𝗠𝗮𝗿𝗸𝗲𝘁𝗶𝗻𝗴 𝗩𝗣𝘀 𝗼𝗳 𝗹𝗲𝗮𝗱𝗶𝗻𝗴 𝗼𝗿𝗴𝗮𝗻𝗶𝘇𝗮𝘁𝗶𝗼𝗻𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗜𝗩𝗙 𝗮𝗻𝗱 𝗳𝗲𝗿𝘁𝗶𝗹𝗶𝘁𝘆 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝘆:
On Monday morning, depending on your country and time zone, you will be receiving this exact direct email from me regarding IVF.com.
𝗠𝘆 𝗻𝗮𝗺𝗲 𝗶𝘀 𝗙𝗿𝗲𝗱 𝗠𝗲𝗿𝗰𝗮𝗹𝗱𝗼, 𝗮𝗻𝗱 𝗜 𝗿𝗲𝗽𝗿𝗲𝘀𝗲𝗻𝘁 𝘁𝗵𝗲 #𝟭 𝗼𝗳𝗳𝗶𝗰𝗶𝗮𝗹 𝗱𝗶𝗴𝗶𝘁𝗮𝗹 𝗯𝗿𝗮𝗻𝗱 𝗶𝗻 𝘆𝗼𝘂𝗿 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝘆: 𝗜𝗩𝗙.𝗰𝗼𝗺.
My message is simple:
𝗗𝗼 𝘁𝗵𝗲 𝗺𝗮𝘁𝗵.
Every major fertility clinic group, reproductive medicine platform, IVF network, genetics company, lab, pharmaceutical company, and patient-acquisition organization is competing for the same patients.
You are all spending heavily on:
Paid search
SEO
Lead generation
Digital advertising
Patient education
Brand trust
Conversion optimization
Market share
And you are doing this in one of the most competitive, emotional, high-value healthcare categories in the world.
𝗜𝗩𝗙.𝗰𝗼𝗺 𝗰𝗵𝗮𝗻𝗴𝗲𝘀 𝘁𝗵𝗲 𝗺𝗮𝘁𝗵.
This is not just an appreciating asset purchase.
It is a market-share acquisition.
It is a trust acquisition.
It is a patient-acquisition advantage.
It is a way to reduce long-term marketing friction, improve credibility, lower effective cost per acquisition, and own the category-defining digital front door for IVF.
At $1.2 million, IVF.com may be the single most strategic marketing and growth decision available to any serious organization in fertility.
A relatively small increase in patient volume could allow this acquisition to pay for itself quickly — 𝗮𝗻𝗱 𝘂𝗻𝗹𝗶𝗸𝗲 𝗮𝗱𝘃𝗲𝗿𝘁𝗶𝘀𝗶𝗻𝗴 𝘀𝗽𝗲𝗻𝗱, 𝗼𝗻𝗰𝗲 𝘆𝗼𝘂 𝗼𝘄𝗻 𝗜𝗩𝗙.𝗰𝗼𝗺, 𝘆𝗼𝘂 𝗼𝘄𝗻 𝗶𝘁 𝗳𝗼𝗿𝗲𝘃𝗲𝗿.
Every marketing executive we have discussed this with immediately understands the power of IVF.com.
𝗪𝗲 𝗯𝗲𝗹𝗶𝗲𝘃𝗲 𝘁𝗵𝗮𝘁 𝗼𝗻𝗰𝗲 𝗮 𝗳𝗶𝗻𝗮𝗻𝗰𝗲 𝗰𝗼𝗺𝗺𝗶𝘁𝘁𝗲𝗲 𝗱𝗼𝗲𝘀 𝘁𝗵𝗲 𝗺𝗮𝘁𝗵 — 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗮𝗰𝗾𝘂𝗶𝘀𝗶𝘁𝗶𝗼𝗻 𝗰𝗼𝘀𝘁, 𝗺𝗮𝗿𝗸𝗲𝘁-𝘀𝗵𝗮𝗿𝗲 𝗴𝗮𝗶𝗻, 𝗰𝗼𝗻𝘃𝗲𝗿𝘀𝗶𝗼𝗻 𝗹𝗶𝗳𝘁, 𝗯𝗿𝗮𝗻𝗱 𝘁𝗿𝘂𝘀𝘁, 𝗮𝗻𝗱 𝗹𝗼𝗻𝗴-𝘁𝗲𝗿𝗺 𝗺𝗮𝗿𝗸𝗲𝘁𝗶𝗻𝗴 𝘀𝗮𝘃𝗶𝗻𝗴𝘀 — 𝘁𝗵𝗶𝘀 𝗮𝘀𝘀𝗲𝘁 𝗯𝗲𝗰𝗼𝗺𝗲𝘀 𝘃𝗲𝗿𝘆 𝗱𝗶𝗳𝗳𝗶𝗰𝘂𝗹𝘁 𝘁𝗼 𝗶𝗴𝗻𝗼𝗿𝗲.
In the right hands, IVF.com is not an expense.
It is a revenue engine and a permanent competitive advantage.
𝗧𝗵𝗲 𝗾𝘂𝗲𝘀𝘁𝗶𝗼𝗻 𝗶𝘀 𝘄𝗵𝗶𝗰𝗵 𝗼𝗿𝗴𝗮𝗻𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝘄𝗶𝗹𝗹 𝗮𝗰𝗾𝘂𝗶𝗿𝗲 𝗶𝘁 𝗯𝗲𝗳𝗼𝗿𝗲 𝗮 𝗰𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗼𝗿 𝗱𝗼𝗲𝘀.
𝗙𝗠@𝗢𝗺𝗻𝗶𝗪𝗼𝗿𝗹𝗱𝗠𝗲𝗱𝗶𝗮.𝗰𝗼𝗺